In this issue:
Rituximab in B-lineage adult ALL
Inotuzumab ozogamicin vs standard therapy for ALL
Does FLT3 mutation impact survival after HCT for AML?
Pretransplant mogamulizumab associated with poor outcomes in adult T-cell leukaemia/lymphoma
Bendamustine + gemcitabine and vinorelbine induction before autoSCT for R/R Hodgkin lymphoma
Risk of relapse independent of treatment in limited-stage DLBCL
Extranodal natural killer T-cell lymphoma: a genome-wide association study
Nivolumab for Hodgkin lymphoma after autoSCT and brentuximab vedotin failure
Obinutuzumab + bendamustine vs bendamustine alone in rituximabrefractory indolent NHL
PEG IFN-α2b + dasatinib in newly diagnosed chronic-phase CML
Please login below to download this issue (PDF)